Prosecution Insights
Last updated: May 29, 2026

Examiner: ALSTRUM ACEVEDO, JAMES HENRY

Tech Center 1600 • Art Units: 1616 1622 1654 1675

This examiner grants 41% of resolved cases

Performance Statistics

40.9%
Allow Rate
-19.1% vs TC avg
442
Total Applications
-20.0%
Interview Lift
1571
Avg Prosecution Days
Based on 440 resolved cases, 2023–2026

Rejection Statute Breakdown

0.1%
§101 Eligibility
3.8%
§102 Novelty
44.7%
§103 Obviousness
7.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18609457 TISSUE FIBROSIS INHIBITOR IN WHICH BIOCOMPATIBLE POLYMER IS USED Non-Final OA KM Biologics Co., Ltd.
18426213 Topical anesthetic agent-clay composite compositions Non-Final OA ANDROS PHARMACEUTICALS CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month